Back to Emergency Medicine
Emergency Medicinev2005Evidence-Based

Pulmonary Embolism Severity Index (PESI)

Predicts 30-day outcome of patients with pulmonary embolism using 11 clinical criteria. This validated prognostic tool stratifies mortality risk into five severity classes to guide treatment decisions and disposition planning, particularly identifying low-risk patients suitable for outpatient management.

Clinical Input Parameters

years
Range: 18 — 120 years
Clinical Assessment
Awaiting Parameters
pesi score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Pulmonary Embolism Severity Index (PESI) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within emergency medicine.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

PESI Score = Age + 10×(if male) + 30×(if cancer) + 10×(if heart failure) + 10×(if chronic lung disease) + 20×(if HR≥110) + 30×(if SBP<100) + 20×(if RR≥30) + 20×(if temp<36°C) + 60×(if altered mental status) + 20×(if O2 sat<90%)

Clinical Pearls & Practice Notes

  • Extensively validated prognostic tool with strong evidence base
  • Age contributes absolute value as points (e.g., 65-year-old gets 65 points for age)
  • Male sex adds 10 points due to higher mortality risk
  • Classes I and II (≤85 points) may be candidates for outpatient management
  • Clinical judgment should always supplement PESI score
  • Does not replace clinical assessment for other contraindications to outpatient treatment
  • Simplified PESI (sPESI) is also available with 6 criteria instead of 11
  • Strong evidence supports use for identifying patients appropriate for outpatient management
  • Area under ROC curve (c-index) of 0.78 in derivation study
  • Validated in over 15,000 patients across multiple studies
  • Recommended by multiple clinical guidelines for PE risk stratification
  • Should be used in conjunction with bleeding risk assessment
  • Does not predict recurrence risk or guide duration of anticoagulation
  • Consider social factors and support systems when making disposition decisions
  • Re-evaluate if clinical condition changes significantly during treatment

Evidence & Literature Citations

  1. Aujesky D, Obrosky DS, Stone RA, Auble TE, Perrier A, Cornuz J, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005;172(8):1041-6. doi: 10.1164/rccm.200506-862OC.
  2. Aujesky D, Roy PM, Verschuren F, Righini M, Osterwalder J, Egloff M, et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet. 2011;378(9785):41-8. doi: 10.1016/S0140-6736(11)60824-6.
  3. Jiménez D, Aujesky D, Moores L, Gómez V, Lobo JL, Uresandi F, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010;170(15):1383-9. doi: 10.1001/archinternmed.2010.199.
  4. Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest. 2016;149(2):315-352. doi: 10.1016/j.chest.2015.11.026.

Score Interpretation Ranges

Class I (Very Low Risk)0 – 65 pts

Very low 30-day mortality risk

Class II (Low Risk)66 – 85 pts

Low 30-day mortality risk

Class III (Intermediate Risk)86 – 105 pts

Intermediate 30-day mortality risk

Class IV (High Risk)106 – 125 pts

High 30-day mortality risk

Class V (Very High Risk)126 – 999 pts

Very high 30-day mortality risk

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.